Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY-NCDermatology practical & conceptual

Successful Treatment of Recalcitrant Pyoderma Gangrenosum with Baricitinib in Two Patients with Rheumatoid Arthritis.

  • Christian Ciolfi1
  • Bernd Raffeiner2
  • Margherita Zen3
  • Anna Giorgia Osele3
  • Jacopo Tartaglia1
  • Stefano Piaserico1
  1. 1Dermatology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy.
  2. 2Department of Rheumatology, Central Hospital of Bolzano (ASAA-SABES), Teaching Hospital of the Paracelsius Medical University, Bolzano, Italy.
  3. 3Division of Rheumatology, Department of Medicine (DIMED), University of Padua, Padua, Italy.
Read full textPDFDOICite

Related

  1. Cardiovascular adverse events of tocilizumab and baricitinib in COVID-19 and rheumatoid arthritis : A real-world disproportionality and machine learning analysis
    Junmo Moon, Chaemin Lee, Seoyeong Lee +8
    MedicinePeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  2. Sustained pain improvement and IL-12-related biomarker changes in rheumatoid arthritis patients initiating baricitinib or TNF inhibitor therapy
    Christine Behrendt, Khetam Ghannam, Monika Brunner-Weinzierl +4
    EULAR Rheumatology OpenPeer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
  3. Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients.
    Irini Flouri, Antonios Bertsias, Konstantina Zoupidou +12
    Rheumatology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Reduction in Rheumatoid Factor and Matrix Metalloproteinase-3 With Successful Glucocorticoid Withdrawal After Initiation of Pemafibrate in a Patient With Rheumatoid Arthritis and Hypertriglyceridemia: A Case Report.
    Kimihiro Suzuki
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  5. Complete Response Demonstrated by [11C]methionine-PET Imaging of a Patient With Squamous-cell Carcinoma of the Tongue Treated With Chemotherapy, Immunotherapy and Methionine Restriction Without Radiation or Surgery: A Potential New Low-toxicity Treatment Paradigm for a Recalcitrant Disease
    TOMOYUKI ISHIGURO, TOSHIHIKO SATO, QINGHONG HAN +6
    In VivoPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC

Cite

BibTeXRIS
BibTeX
@article{ciolfi2026successful,
  title = {{Successful Treatment of Recalcitrant Pyoderma Gangrenosum with Baricitinib in Two Patients with Rheumatoid Arthritis.}},
  author = {Christian Ciolfi and Bernd Raffeiner and Margherita Zen and Anna Giorgia Osele and Jacopo Tartaglia and Stefano Piaserico},
  journal = {Dermatology practical \& conceptual},
  year = {2026},
  month = jul,
  doi = {10.5826/dpc.1603a7240},
  url = {https://europepmc.org/article/MED/42858393},
  note = {CC BY-NC},
}
RIS
TY  - JOUR
TI  - Successful Treatment of Recalcitrant Pyoderma Gangrenosum with Baricitinib in Two Patients with Rheumatoid Arthritis.
AU  - Christian Ciolfi
AU  - Bernd Raffeiner
AU  - Margherita Zen
AU  - Anna Giorgia Osele
AU  - Jacopo Tartaglia
AU  - Stefano Piaserico
PY  - 2026
DA  - 2026/07/31
JO  - Dermatology practical & conceptual
DO  - 10.5826/dpc.1603a7240
UR  - https://europepmc.org/article/MED/42858393
SN  - 2160-9381
ER  -